OR WAIT null SECS
April 17, 2018
According to Alexion, the acquisition will help rebuild its clinical pipeline.
April 09, 2018
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
National Institutes of Health researchers use genomics to show that squamous cell carcinomas differ from other cancers, which could advance treatments for head and neck and other cancers.
March 29, 2018
The acquisition strengthens Celgene’s position in the global cellular immunotherapy space.
The companies will co-develop and co-promote a CAR T cell therapy in the United States.
March 23, 2018
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
March 19, 2018
Biogen will acquire an AMPA receptor potentiator for cognitive impairment associated with schizophrenia in a deal worth approximately $590 million.
The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.
March 13, 2018
The $11.6-billion acquisition strengthens Sanofi's position in hematology and specialty medicines.